04:24 AM EDT, 05/09/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) reported fiscal Q4 core earnings Thursday of 72 yen ($0.46) per basic share, down from 102 yen a year earlier.

Analysts' estimates were not readily available for comparison.

Revenue for the quarter ended March 31 was 1.051 trillion yen, up from 956.2 billion yen a year earlier.

Analysts surveyed by Capital IQ expected 899.9 billion yen.

For fiscal 2024, the Japanese pharmaceutical company expects core earnings of 431 yen per share on revenue of 4.35 trillion yen. Analysts surveyed by Capital IQ expect revenue of 4.028 trillion yen.

Takeda was up more than 2% in Wednesday's after-hours activity.

Price: 13.40, Change: +0.34, Percent Change: +2.60